A new study
has suggested that women who are at a high risk for breast cancer have a
greater chance of recurrence if they do not have BRCA 1 and 2 mutations.
The finding
also raises questions about the use of sentinel node biopsy with prophylactic
mastectomies in high-risk women.
The
increased risk of developing breast cancer is already understood for women with
the disease who test positive for a BRCA1 or 2 mutation.
Many of
these women opt to have their breast surgically removed (prophylactic
mastectomy) to cut their risk of developing breast cancer or developing a
second breast cancer. The role of sentinel node biopsy remains controversial in
this group.
"We
know more about counselling women regarding prophylactic mastectomy if they
have a BRCA mutation," said lead author Shawna C. Willey, MD, FACS, a
member of the Breast Cancer Program at the Lombardi Comprehensive Cancer Center
and director of the Betty Lou Ourisman Breast Health Center at Georgetown
University Hospital.
"In
high-risk women who have cancer but dont have a known mutation, we generally
advise that the risk of developing a second cancer in the same or opposite
breast is lower than it is for women who test positive for a mutation. This
latest analysis has us re-thinking our approach," Willey added.
The study
recruited women in a familial cancer registry at Lombardi who were enrolled
between 1998 and 2007. The registry participants had at least a 10 percent
probability of carrying a BRCA1/2 mutation based on personal or family history
of cancer.
The cohort
for the study involved 119 women. 74 women had a BRCA mutation (group 1) and 45
did not test positive for the mutation (group 2).